VentriPoint Diagnostics (TSE:VPT) has released an update.
Ventripoint Diagnostics Ltd., known for its AI-driven echocardiography advancements, has partnered with Empire Relations Group Inc. (ERG) to enhance investor relations over a four-month period with an optional extension. The collaboration is aimed at engaging professional investors interested in innovative medical technologies, and is subject to TSX Venture Exchange approval.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
